A retrospective cohort study combining data from 1998 through 2007 from 4 large US data systems (Kaiser Permanente Northern California, 2 pharmaceutical assistance programs for the elderly, Tennessee Medicaid, and US Medicaid/Medicare programs), comparing non-viral infection rates of new users of TNF-ɑ inhibitors to non-biologic drugs. The gene discussed is TNF; the disease is viral infectious disease.